This is a past event. Registration is closed. View other Corporate Council on Africa events.
Dr. Jeffrey L. Sturchio
Chairman of the Board at Corporate Council on AfricaJeffrey L. Sturchio is the Chairman of Corporate Council on Africa. He recently retired as the President and CEO at Rabin Martin, a global health strategy consulting firm, and former President and CEO of the Global Health Council. Before joining the Council in 2009, Dr. Sturchio was vice president of Corporate Responsibility at Merck & Co. Inc., president of The Merck Company Foundation and joined as chairman of the U. S. Corporate Council on Africa (CCA), whose 160 member companies represent some 85 percent of total US private sector investment in Africa. While at Merck & Co., Inc., for more than a decade he was a leader of the company’s global HIV/AIDS policy and was centrally involved in the UN/Industry Accelerating Access Initiative established in 2000 to help improve HIV/AIDS care and treatment in the developing world. He was a member of the board of the African Comprehensive HIV/AIDS Partnerships in Botswana (2005-2009) and a member of the private sector delegation to the Board of the Global Fund to Fight AIDS, TB and Malaria (2002-2008).
He is chairman of the Corporate Council on Africa, chairman of the BroadReach Institute for Training and Education and a member of the boards of ACHAP, Friends of the Global Fight Against AIDS and the Museum of AIDS in Africa. Dr. Sturchio is also currently a visiting scholar at the Institute for Applied Economics, Global Health and the Study of Business Enterprise at The Johns Hopkins University; Senior Associate at the Center for Strategic and International Affairs; a principal of the Modernizing Foreign Assistance Network; Fellow of the American Association for the Advancement of Science; a member of the Council on Foreign Relations and the Arthur W. Page Society; and an advisor to amfAR, the Clinton Global Initiative, Intrahealth International and the NCD Alliance. He received an AB in history from Princeton University and a PhD in the history and sociology of science from the University of Pennsylvania. His publications include Noncommunicable diseases in the developing world: addressing global gaps in policy and research (edited with L. Galambos, Johns Hopkins University Press, 2013).
Mrs. Sybil Nana Ama Ossei-Agyeman-Yeboah
Acting Principle Professional Officer Public Health at West African Health OrganizationSybil Nana Ama OSSEI-AGYEMAN-YEBOAH, BPharm, Msc-Pharm & Quality Assurance, CIAMC-GH, FPCPharm, FGCPharm, PMP, PhD candidate in Public Health Administration and Policy (Walden University-USA).
A Pharmacist with 33 years’ experience and 23 years as Pharmaceutical and Quality Assurance Analyst. Holds BPharm (1989) and MSc. in Pharmaceutical and Quality Control (1999) from KNUST-Ghana respectively. A PhD candidate in Public Health Administration and Policy (Walden University-USA). Project Management Professional (GIMPA) (2020). IEMA, CQI & IRCA Certified Lead Auditor for ISO (9001, 14001 and 17025) 2021/2022. Fellow of the West Africa Postgraduate College of Pharmacists (2018), Fellow Ghana Post Graduate College of Pharmacists (2016). Chartered Institute of Administration and Management Consultant, Ghana- Practicing License (2007). Had worked in various capacities in the teaching and health institutions in Ghana. For the past 12 years plus has been with the West African Health Organization (WAHO) as the Professional Officer in charge of Pharmaceuticals, now the Ag. Principal Program Officer for Public Health and Head of Division. Coordinates the West Africa Medicines Regulatory Harmonization Initiative, train and develop regional experts in the pharmaceutical sectors to strengthen the human resource for the work force, strengthening medicines regulatory systems, quality control laboratories capacity, ensuring the accreditations of the national regulatory agencies and laboratories to international standards, local pharmaceutical manufacturing capacities development, establishing good manufacturing practices. These and other interventions undertaken are to ensure best health practices and access to quality, safe and affordable medical products in the Economic Community of West African States (ECOWAS). Coordinating the ECOWAS COVID-19 vaccines Taskforce to ensure effective access of COVID-19 vaccines and other vaccines production in the region. Have good working relationships with stakeholders and partners.
Dr. David Mukanga
Deputy Director, Africa Regulatory Systems, Integrated Development, Global Health Division of Bill and Melinda Gates FoundationDr. David Mukanga is Senior Program Officer, Africa Regulatory Systems at the Bill and Melinda Gates Foundation, where he leads the foundation’s Africa regulatory systems optimization portfolio. In this role, David supports the development of harmonized, transparent and predictable regulatory systems covering the lifecycle of medical products in Africa, as well regulatory emergency preparedness.
In this role he works side by side with partners on the African continent (including the World Health Organization, African
Union Commission, African Union Development Agency, Regional Economic Communities, and others) to facilitate development of new medical products, as well as patient access to quality essential medicines.
Dr. Mukanga has a combined 22 years of experience spanning regulatory affairs, child survival and development, epidemic preparedness and response, clinical research and product development, and academia. David received his professional training at Makerere University, the Johns Hopkins Bloomberg School of Public Health, and the Karolinska Institute.
Ms. Nevena Miletic
Co-Chair African Regulatory Network at IFPMARegulatory Policy Lead, Global Regulatory Policy, F. Hoffmann-La Roche (IFPMA Africa Regulatory Network Co-chair)
Nevena Miletic is a Regulatory and Policy professional, passionate about bringing innovative therapeutic solutions to patients in need around the world.
She is a pharmacist, with postgraduate studies in pharmacoeconomics, regulatory affairs and quality assurance, and a certified QP, with almost two decades of experience in pharmaceutical industry.
Currently she works in the Global Regulatory Policy group in F. Hoffmann-La Roche, Switzerland, and for the last six years, she is chairing IFPMA Africa Regulatory Network.
She is also a member of research-based pharmaceutical companies associations and boards (IFPMA Regulatory Science Committee, IFPMA Africa Engagement Committee, DIA Middle East & Africa Advisory Board, EFPIA ERAO, IATF etc.), involved in numerous meetings, workshops and projects with regulators, cross-industry and public-private collaborative platforms (e.g. Pre-ICDRA, ICDRA, SCoMRA, IMI/IHI etc.).
She is leading internal Roche policy efforts and projects focusing on digitalization and e labeling. In addition, she is a lead Roche representative in IMI project Gravitate Health, as well as in EFPIA ERAO PI working group and IATF (EU Inter-Associations (EFPIA/M4EU/AESGP) Task Force on PI).
Ms. Miletic is strong advocate for regulatory convergence and harmonization, as well as for modernization of regulatory frameworks to enable innovative approaches in drug development and review.
Mr. Emanuel Owusu Adasi
Information Technology Officer at Ghana Food and Drugs AuthorityEmmanuel Owusu Adasi is an Information Technology Officer with the Information Management & Technology Solutions Department of the Food and Drugs Authority Ghana. He holds a Bachelor of Science (Hons) degree in Information Technology from Pentecost University, Accra, Ghana. Emmanuel has worked with the Food and Drugs Authority for ten years, where he brings his knowledge, skills, and experience to bear.
He is currently a member of the Technical Committee for African Medicines Regulatory Harmonization on Developing Continental Information Management System for Africa. Emmanuel also is a member of the Food and Drugs Authority Paperless Project Implementation Committee.